Latest Cinclus Pharma News & Updates

See the latest news and media coverage for Cinclus Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Cinclus Pharma

Clinical-stage pharmaceutical company

cincluspharma.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Private company
Number of employees
2–30

Last updated

Latest news about Cinclus Pharma

In short: Cinclus Pharma completed Phase III screening for linaprazan glurate and secured €28 million in financing to support the drug's clinical development.

Company announcements

Cinclus Pharma

Cinclus Pharma announces AGM resolutions

On 21 May 2026 Cinclus re-elected and appointed board members, approved fees and remuneration report, authorized share issues, adopted a 2026–2029 performance share program, and resolved no dividend.

Cinclus Pharma

Cinclus Pharma publishes its 2025 Annual Report

The report is available online in ESEF format. CEO highlights Phase III progress, Zentiva licensing, and China launch plans.

Unlock all announcements with a

Media coverage

Marketscreener

Cinclus Pharma secures financing of up to 28 million euros | MarketScreener

The pharmaceutical development company Cinclus Pharma has entered into a financing agreement with Claret Capital Partners for up to 28 million euros. The capital will...

Unlock all articles with a

Never miss news about Cinclus Pharma

Track Cinclus Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.